Author(s): Guslandi M
Abstract Share this page
Abstract Intestinal bacteria play a role in the development of non-steroidal anti-inflammatory drugs (NSAID)-induced small intestinal injury. Agents such as probiotics, able to modify the gut ecology, might theoretically be useful in preventing small intestinal damage induced by NSAIDs. The clinical studies available so far do suggest that some probiotic agents can be effective in this respect.
This article was published in World J Gastroenterol
and referenced in Pharmaceutica Analytica Acta